Figure 1
Figure 1. Gating strategy used to select cell subpopulations for signal-transduction pathway analysis. (A) The CD45-APC-A750/side scatter (SS) pattern was used to isolate lymphocytes from nonlymphocytes, define a generous “blast” region, and exclude nucleated erythrocytes from the analysis. (B) Blasts were further enriched for CD34 and CD117 as shown using CD64-PE and SS characteristics to exclude potential contaminating monocytes and maturing granulocytic cells. (C) CD34 and CD117 profiles from this enriched region were used for defining the CD34-ECD+CD117-PC5.5+ and CD34-ECD−CD117-PC5.5+ populations as shown. (D) Mature monocyte and granulocyte enriched regions were defined based on combining the nonlymphocyte gate and CD64-PE and SS light characteristics as shown. (E) The defined granulocyte-enriched region was then further subdivided into immature granulocytes, intermediate granulocytes, and mature granulocytes based on CD13-PC7 and CD16-A700 characteristics as shown. This scheme defines 6 regions (CD34+/CD117+; CD34−/CD117+, immature, intermediate and mature granulocytes, and monocytes) from which signaling data were derived. Acquired on Gallios flow cytometer and analyzed with FCS Express Version 3.

Gating strategy used to select cell subpopulations for signal-transduction pathway analysis. (A) The CD45-APC-A750/side scatter (SS) pattern was used to isolate lymphocytes from nonlymphocytes, define a generous “blast” region, and exclude nucleated erythrocytes from the analysis. (B) Blasts were further enriched for CD34 and CD117 as shown using CD64-PE and SS characteristics to exclude potential contaminating monocytes and maturing granulocytic cells. (C) CD34 and CD117 profiles from this enriched region were used for defining the CD34-ECD+CD117-PC5.5+ and CD34-ECDCD117-PC5.5+ populations as shown. (D) Mature monocyte and granulocyte enriched regions were defined based on combining the nonlymphocyte gate and CD64-PE and SS light characteristics as shown. (E) The defined granulocyte-enriched region was then further subdivided into immature granulocytes, intermediate granulocytes, and mature granulocytes based on CD13-PC7 and CD16-A700 characteristics as shown. This scheme defines 6 regions (CD34+/CD117+; CD34/CD117+, immature, intermediate and mature granulocytes, and monocytes) from which signaling data were derived. Acquired on Gallios flow cytometer and analyzed with FCS Express Version 3.

Close Modal

or Create an Account

Close Modal
Close Modal